NASDAQ:IRMD IRadimed (IRMD) Stock Forecast, Price & News $48.00 +0.97 (+2.06%) (As of 06/1/2023 ET) Add Compare Share Share Today's Range$46.97▼$48.3850-Day Range$38.04▼$48.4952-Week Range$26.00▼$49.30Volume17,188 shsAverage Volume38,880 shsMarket Capitalization$604.80 millionP/E Ratio44.04Dividend YieldN/APrice Target$49.00 ProfileProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability IRadimed MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside2.1% Upside$49.00 Price TargetShort InterestHealthy1.20% of Float Sold ShortDividend StrengthN/ASustainability-0.85Upright™ Environmental ScoreNews Sentiment0.67Based on 2 Articles This WeekInsider TradingSelling Shares$4.38 M Sold Last QuarterProj. Earnings Growth21.37%From $1.17 to $1.42 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.41 out of 5 starsMedical Sector457th out of 1,980 stocksSurgical & Medical Instruments Industry47th out of 200 stocks 1.5 Analyst's Opinion Consensus RatingIRadimed has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $49.00, IRadimed has a forecasted upside of 2.1% from its current price of $48.00.Amount of Analyst CoverageIRadimed has only been the subject of 1 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted1.20% of the float of IRadimed has been sold short.Short Interest Ratio / Days to CoverIRadimed has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous month Previous Next 0.0 Dividend Strength Dividend YieldIRadimed does not currently pay a dividend.Dividend GrowthIRadimed does not have a long track record of dividend growth. Previous Next 4.4 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreIRadimed has received a 67.92% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is false driven by its "Real-time vital parameter monitors for MRI machines", "Intravenous therapy equipment for MRI machines", and "ECG monitors" products. See details.Environmental SustainabilityThe Environmental Impact score for IRadimed is -0.85. Previous Next 2.6 News and Social Media Coverage News SentimentIRadimed has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.47 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for IRadimed this week, compared to 2 articles on an average week.MarketBeat Follows8 people have added IRadimed to their MarketBeat watchlist in the last 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, IRadimed insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,382,197.00 in company stock.Percentage Held by Insiders43.70% of the stock of IRadimed is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions50.03% of the stock of IRadimed is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for IRadimed are expected to grow by 21.37% in the coming year, from $1.17 to $1.42 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of IRadimed is 44.04, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 136.06.Price to Earnings Ratio vs. SectorThe P/E ratio of IRadimed is 44.04, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 123.01.Price to Book Value per Share RatioIRadimed has a P/B Ratio of 9.39. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About IRadimed (NASDAQ:IRMD) StockIRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices. It also provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.Read More Receive IRMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IRadimed and its competitors with MarketBeat's FREE daily newsletter. Email Address IRMD Stock News HeadlinesMay 26, 2023 | americanbankingnews.comRoger E. Susi Sells 10,000 Shares of IRadimed Co. (NASDAQ:IRMD) StockMay 18, 2023 | finance.yahoo.comiRadimed (IRMD) Is a Great Choice for 'Trend' Investors, Here's WhyJune 1, 2023 | Legacy Research (Affiliate) (Ad)“Amazon Loophole” could hand you $28,544 in “royalty” payoutsThanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.May 16, 2023 | finance.yahoo.comIRadimed Corporation's (NASDAQ:IRMD) Stock Is Going Strong: Is the Market Following Fundamentals?May 13, 2023 | americanbankingnews.comIRadimed Co. (NASDAQ:IRMD) CEO Sells $119,091.16 in StockMay 12, 2023 | americanbankingnews.comInsider Selling: IRadimed Co. (NASDAQ:IRMD) Director Sells 2,786 Shares of StockMay 11, 2023 | americanbankingnews.comIRadimed Co. (NASDAQ:IRMD) CEO Sells $462,000.00 in StockMay 10, 2023 | finance.yahoo.comIRADIMED CORPORATION Named a 2023 Best Small Company in America by ForbesJune 1, 2023 | Legacy Research (Affiliate) (Ad)“Amazon Loophole” could hand you $28,544 in “royalty” payoutsThanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.May 10, 2023 | americanbankingnews.comIRadimed (NASDAQ:IRMD) Rating Lowered to Buy at StockNews.comMay 4, 2023 | finance.yahoo.comIRADIMED CORPORATION Announces First Quarter 2023 Financial ResultsMay 4, 2023 | finance.yahoo.comIRadimed (IRMD) Surpasses Q1 Earnings and Revenue EstimatesMay 3, 2023 | benzinga.comiRadimed Stock (NASDAQ:IRMD), DividendsMay 2, 2023 | americanbankingnews.comHead to Head Comparison: IRadimed (NASDAQ:IRMD) and Valeritas (OTCMKTS:VLRXQ)April 27, 2023 | finance.yahoo.comIRADIMED CORPORATION to Hold 2023 First Quarter Financial Results Conference Call on May 4thApril 17, 2023 | finance.yahoo.comIRadimed's (NASDAQ:IRMD) investors will be pleased with their solid 162% return over the last five yearsApril 14, 2023 | americanbankingnews.comIRadimed (NASDAQ:IRMD) Now Covered by Lake Street CapitalApril 14, 2023 | americanbankingnews.comInsider Selling: IRadimed Co. (NASDAQ:IRMD) CEO Sells 10,000 Shares of StockApril 7, 2023 | americanbankingnews.comStockNews.com Upgrades IRadimed (NASDAQ:IRMD) to "Strong-Buy"April 6, 2023 | americanbankingnews.comInsider Selling: IRadimed Co. (NASDAQ:IRMD) CEO Sells $387,100.00 in StockMarch 30, 2023 | americanbankingnews.comIRadimed Co. (NASDAQ:IRMD) CEO Roger E. Susi Sells 10,000 SharesMarch 27, 2023 | finance.yahoo.comWith 43% ownership, IRadimed Corporation (NASDAQ:IRMD) insiders have a lot at stakeMarch 22, 2023 | americanbankingnews.comIRadimed (NASDAQ:IRMD) vs. Akili (NASDAQ:AKLI) Financial ComparisonMarch 6, 2023 | finance.yahoo.comIRADIMED CORPORATION To Present at the 35th Annual Roth ConferenceFebruary 27, 2023 | finance.yahoo.comIradimed Notifies Potential Issue With Certain Syringe Adapter Sets During UseFebruary 24, 2023 | finance.yahoo.comIRADIMED CORPORATION Issues Urgent Medical Device CorrectionFebruary 6, 2023 | finance.yahoo.comWinter Springs MRI tech firm Iradimed buys Orlando land for new manufacturing plantSee More Headlines IRMD Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IRMD Company Calendar Last Earnings5/04/2023Today6/01/2023Next Earnings (Estimated)8/04/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:IRMD CUSIPN/A CIK1325618 Webwww.iradimed.com Phone(407) 677-8022Fax407-677-5037Employees110Year FoundedN/APrice Target and Rating Average Stock Price Forecast$49.00 High Stock Price Forecast$50.00 Low Stock Price Forecast$48.00 Forecasted Upside/Downside+2.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)$1.09 Trailing P/E Ratio44.04 Forward P/E Ratio41.03 P/E GrowthN/ANet Income$12.83 million Net Margins24.27% Pretax Margin30.94% Return on Equity20.03% Return on Assets17.33% Debt Debt-to-Equity RatioN/A Current Ratio9.07 Quick Ratio8.14 Sales & Book Value Annual Sales$53.30 million Price / Sales11.35 Cash Flow$1.11 per share Price / Cash Flow43.05 Book Value$5.11 per share Price / Book9.39Miscellaneous Outstanding Shares12,600,000Free Float7,091,000Market Cap$604.80 million OptionableNot Optionable Beta1.06 Key ExecutivesRoger SusiChairman, President & Chief Executive OfficerJohn F. GlennChief Financial Officer & SecretaryChris WilliamsonVice President-Information TechnologyLynn NeuhardtVice President-Research & DevelopmentRandy WaddellVP-Worldwide Sales & MarketingKey CompetitorsArtivionNYSE:AORTOrchestra BioMedNASDAQ:OBIOMiMedx GroupNASDAQ:MDXGOrthofix MedicalNASDAQ:OFIXTactile Systems TechnologyNASDAQ:TCMDView All CompetitorsInsiders & InstitutionsRoger E SusiSold 5,825 sharesTotal: $269,522.75 ($46.27/share)Capital Impact Advisors LLCSold 980 shares on 5/23/2023Ownership: 0.154%Roger E SusiSold 10,000 sharesTotal: $459,500.00 ($45.95/share)Ameriprise Financial Inc.Bought 3,216 shares on 5/22/2023Ownership: 0.160%JPMorgan Chase & Co.Bought 4,783 shares on 5/18/2023Ownership: 0.070%View All Insider TransactionsView All Institutional Transactions IRMD Stock - Frequently Asked Questions Should I buy or sell IRadimed stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IRadimed in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" IRMD shares. View IRMD analyst ratings or view top-rated stocks. What is IRadimed's stock price forecast for 2023? 1 brokerages have issued 12 month price objectives for IRadimed's stock. Their IRMD share price forecasts range from $48.00 to $50.00. On average, they predict the company's share price to reach $49.00 in the next year. This suggests a possible upside of 2.1% from the stock's current price. View analysts price targets for IRMD or view top-rated stocks among Wall Street analysts. How have IRMD shares performed in 2023? IRadimed's stock was trading at $28.29 at the start of the year. Since then, IRMD shares have increased by 69.7% and is now trading at $48.00. View the best growth stocks for 2023 here. When is IRadimed's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, August 4th 2023. View our IRMD earnings forecast. How were IRadimed's earnings last quarter? IRadimed Co. (NASDAQ:IRMD) announced its earnings results on Thursday, May, 4th. The medical equipment provider reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.02. The medical equipment provider earned $15.48 million during the quarter, compared to the consensus estimate of $14.76 million. IRadimed had a net margin of 24.27% and a trailing twelve-month return on equity of 20.03%. How often does IRadimed pay dividends? What is the dividend yield for IRadimed? IRadimed announced a dividend on Monday, February 6th. Investors of record on Monday, February 13th will be paid a dividend of $1.05 per share on Tuesday, February 21st. This represents a dividend yield of 2.54%. The ex-dividend date is Friday, February 10th. This is a positive change from the stock's previous dividend of $1.00. Read our dividend analysis for IRMD. What ETFs hold IRadimed's stock? ETFs with the largest weight of IRadimed (NASDAQ:IRMD) stock in their portfolio include Ballast Small/Mid Cap ETF (MGMT), Janus Henderson Small Cap Growth Alpha ETF (JSML), Royce Quant Small-Cap Quality Value ETF (SQLV), What guidance has IRadimed issued on next quarter's earnings? IRadimed updated its second quarter 2023 earnings guidance on Thursday, May, 4th. The company provided EPS guidance of $0.30-$0.32 for the period, compared to the consensus EPS estimate of $0.30. The company issued revenue guidance of $15.60 million-$15.80 million, compared to the consensus revenue estimate of $15.10 million. What other stocks do shareholders of IRadimed own? Based on aggregate information from My MarketBeat watchlists, some companies that other IRadimed investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Alphabet (GOOG), Mastercard (MA), Micron Technology (MU), PayPal (PYPL), CRISPR Therapeutics (CRSP), IntriCon (IIN), QUALCOMM (QCOM) and Twitter (TWTR). What is IRadimed's stock symbol? IRadimed trades on the NASDAQ under the ticker symbol "IRMD." Who are IRadimed's major shareholders? IRadimed's stock is owned by a number of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (4.61%), BlackRock Inc. (3.52%), RK Capital Management LLC (2.66%), Bares Capital Management Inc. (2.52%), Russell Investments Group Ltd. (1.69%) and Ranger Investment Management L.P. (1.63%). Insiders that own company stock include Anthony Vuoto, Christopher K Scott, James B Hawkins, Monty K Allen, Monty K Allen and Roger E Susi. View institutional ownership trends. How do I buy shares of IRadimed? Shares of IRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is IRadimed's stock price today? One share of IRMD stock can currently be purchased for approximately $48.00. How much money does IRadimed make? IRadimed (NASDAQ:IRMD) has a market capitalization of $604.80 million and generates $53.30 million in revenue each year. The medical equipment provider earns $12.83 million in net income (profit) each year or $1.09 on an earnings per share basis. How many employees does IRadimed have? The company employs 110 workers across the globe. How can I contact IRadimed? IRadimed's mailing address is 1025 Willa Springs Dr., Winter Springs FL, 32708. The official website for the company is www.iradimed.com. The medical equipment provider can be reached via phone at (407) 677-8022, via email at investorrelations@iradimed.com, or via fax at 407-677-5037. This page (NASDAQ:IRMD) was last updated on 6/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IRadimed Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.